To determine the target of the recently identified lead compound NSC130362 that is responsible for its 22 selective anti-cancer efficacy and safety in normal cells, structure-activity relationship (SAR) studies were 23 conducted. First, NSC13062 was validated as a starting compound for the described SAR studies in a variety of 24 cell-based viability assays. Then, a small library of 1,4-naphthoquinines (1,4-NQs) and quinoline-5,8-diones was 25 2 tested in cell viability assays using pancreatic cancer MIA PaCa-2 cells and normal human hepatocytes. The 26 obtained data allowed us to select a set of both non-toxic compounds that preferentially induced apoptosis in 27 cancer cells and toxic compounds that induced apoptosis in both cancer and normal cells. Anti-cancer activity of 28 the selected non-toxic compounds was confirmed in viability assays using breast cancer HCC1187 cells. 29 Consequently, the two sets of compounds were tested in multiple cell-based and in vitro activity assays to identify 30 key factors responsible for the observed activity. Inhibition of the mitochondrial electron transfer chain (ETC) is 31 a key distinguishing activity between the non-toxic and toxic compounds. Finally, we developed a mathematical 32 model that was able to distinguish these two sets of compounds. The development of this model supports our 33 conclusion that appropriate quantitative SAR (QSAR) models have the potential to be employed to develop anti-34 cancer compounds with improved potency while maintaining non-toxicity to normal cells. 35 36 37
A, Structure of NSC130362. B, Dose response curve of NSC130362 in MIA PaCa-2 cells. Cells were pre-150 incubated with NSC130362 for 2 h followed by addition of ATO (5 M) and incubation for an additional 24 h. 151 At the end of the treatment, the ratio of dead cells was determined by a CellTiterGlo reagent. P0.05. 152 NSC130362 is a 1,4-NQ. Quinone moieties are present in many drugs such as anthracyclines, daunorubicin, 153 doxorubicin, mitomycin, and saintopin, which are used in anti-cancer therapy [16] . The effects of quinones on 154 cell viability are mainly due to generation of reactive oxygen species (ROS) or to covalent attachment to 155 biomolecules via arylation reactions [16, 21] . In addition to their ability to induce oxidative stress, ROS-156 generating agents can also potentiate the ability of clinical drugs to induce apoptosis in cancer cells [22] [23] [24] . To First, we analyzed 2-chloro-3-amino-1,4-NQ and 2-chloro-3-(alkylamino)-1,4-NQs (Table 1) . SAR results 225 showed that the cytotoxic activity of compounds 1-9 in cancer cells depends on the size of the 3-substituent. The 226 anti-cancer potency and safety index decreased with increased length of the substituent. When compounds with 227 branched 3-(alkylamino) substituent (compounds 10-13) were analyzed, we also noticed a decrease in cytotoxic 228 activity and safety index when the length of alkyl chain is changed from isopropyl (compounds 10) to either sec-229 butyl or isobutyl (compounds 11 and 12, respectively). However, when the alkyl group was tert-butyl (compounds 230 13) there was a significant increase in the anti-cancer activity and safety index. We conclude that the shape of 4-231 carbon alkyl group plays an important role in the biological activity of the analyzed compounds. The importance 232 of the shape of the alkyl substituent in 2-chloro-3-(alkylamino)-1,4-NQs can be drawn from study of compounds 233 14-16. In this case, when two hydrogens of the amino group are substituted by either two methyl groups 234 (compound 14) or aziridine groups (compound 15), the resulting compounds have similar cytotoxic activity in 235 MIA PaCa-2 cells to a compound when one hydrogen of the amino group is substituted by the methyl group 236 (compound 2). However, the effect of these substitutions on toxicity to hepatocytes was more pronounced.
237
Compounds 14 and 15 were approximately 2 and 6.5 times more toxic toward hepatocytes than compound 2, 238 respectively. Strikingly, when two methyl groups were attached to the aziridine group (compound 16), the 239 compound became completely non-toxic against normal cells, while maintaining almost identical levels of anti-240 cancer activity with that of compound 15. These data showed again that the shape of the 3-substituent is an 241 important factor, which is responsible for the compound's biological activity. Unfortunately, the steric 242 contribution of the 3-position substituents is difficult to predict due to the absence of data regarding target 243 protein/compound interactions. 13 to generate compound 20, resulted in approximately 50-and 2-fold loss in anti-cancer activity and toxicity to hepatocytes, respectively. These data suggest that the effect of hydroxyl group in the 3-alkylamino substituent is 266 variable and depends on the length and shape of the alkyl chain. 267 We also analyzed the effect of different alkoxyamino substituents on biological activity of 2-chloro-3- fold improved anti-cancer activity without significant effect on toxicity to hepatocytes as compared to compound not affect the ability of NSC130362 to inhibit GSR and cause oxidative stress. Based on this information, we 316 selected the next set of 1,4-NQs that do not contain 2-chloro substituent ( Table 2 . EC50 values and the safety index of the NSC130362 analogs that do not contain 2-chloro substituent in influences the effect of the naphthalene/quinoline exchange on either the anti-cancer activity or toxicity to Activities of the selected NSC130362 analogs. For further analyses, we used compounds that have the safety 381 index either above 20 (non-toxic compounds) or below 1 (toxic compounds) with the aim to identify targets that 382 are responsible for the selective activity of the identified compounds toward cancer cells. To confirm that the 383 effects of the selected compounds are not only specific to MIA PaCa-2 cells, we evaluated their cytotoxic 384 activities on breast carcinoma HCC1187 cells (Table 4 ). HCC1187 cells were chosen because these cells are 385 highly responsive to ROS [8] . For easy comparison, the data with MIA PaCa-2 cells were also included in Table   386 4. With only a few exceptions, all non-toxic compounds had a safety index above 10 in HCC1187 cells. We also 
